1026353-20-7,
Telmisartan related compound B,
UNII-3178N39Y2I,
3178N39Y2I,
(1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,7'-dimethyl-2'-propyl(2,5'-bi-1H-benzimidazol)-1'-yl)methyl)-,
2-[4-[[7-methyl-5-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid,
4'-((7-Methyl-5-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl)methyl)biphenyl-2-carboxylic acid,
4'-[(1,7'-Dimethyl-2'-propyl[2,5'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic Acid,
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,7'-dimethyl-2'-propyl[2,5'-bi-1H-benzimidazol]-1'-yl)methyl]-,
4'-[[7-Methyl-5-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic Acid,
Telmisartan related compound B [USP],
Telmisartan specified impurity B [EP],
Telmisartan related compound B RS [USP],
BIP036,
SCHEMBL12630252,
ZINC34110189,
4'-((1,7'-Dimethyl-2'-propyl-1H,1'H-[2,5'-bibenzo[d]imidazol]-1'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid,
4'-(1,7'-Dimethyl-2'-propyl-2,5'-bi[1H-benzoimidazole]-1'-ylmethyl)biphenyl-2-carboxylic acid,
TELMISARTAN RELATED COMPOUND B (15 MG) (4'-[(1,7'-DIMETHYL-2'-PROPYL-1H,1'H-2,5'-BIBENZO[D]IMIDAZOL-1'-YL)METHYL]BIPHENYL-2-CARBOXYLIC ACID),
Telmisartan EP Impurity B,
CS-O-08259,
CID10029467,
CID 10029467,